Michael Raab

Michael Raab has an estimated net worth of $20.7 Million. This is based on reported shares across multiple companies, which include AMICUS THERAPEUTICS, INC., Tempest Therapeutics, Inc., ARDELYX, INC., Transcept Pharmaceuticals Inc, and INTARCIA THERAPEUTICS, INC.

2024 was Michael Raab's most active year for acquiring shares with 12 total transactions. Michael Raab's most active month to acquire stocks was the month of May. 2024 was Michael Raab's most active year for disposing of shares, totalling 29 transactions. Michael Raab's most active month to dispose stocks was the month of March. 2021 saw Michael Raab paying a total of $187,254.72 for 1,290,722 shares, this is the most they've acquired in one year. In 2026 Michael Raab cashed out on 652,969 shares for a total of $2,714,671.51, their largest year based on trade value.